Related Experiment Videos
Increased immunoglobulin E response in acute coronary syndromes
Okan Erdogan1, Cetin Gul, Armagan Altun
1Department of Cardiology, School of Medicine, Trakya University, Edirne, Turkey. okanerdogan@yahoo.com
Angiology
|February 21, 2003
Summary
Elevated immunoglobulin E (IgE) levels are linked to acute coronary syndromes, indicating inflammation and mast cell activation in plaque rupture. These IgE levels rise during the acute phase and then decrease, supporting their role in heart attack events.
Area of Science:
- Cardiology
- Immunology
- Inflammation research
Background:
- Inflammation and mast cell activation are implicated in atherosclerotic plaque destabilization.
- Immunoglobulin E (IgE) involvement in acute coronary syndromes requires further investigation.
Purpose of the Study:
- To investigate the role of immunoglobulin E (IgE) in acute coronary syndromes (ACS).
- To compare IgE levels in patients with acute myocardial infarction (AMI), unstable angina pectoris (UAP), stable angina pectoris (SAP), and healthy controls.
Main Methods:
- Prospective clinical study measuring serial IgE levels in AMI and UAP patients.
- IgE levels measured on days 1, 3, 7, 21, and 3 months post-admission.
- Blood eosinophil and basophil counts assessed on admission across all groups.
Main Results:
- Initial IgE levels were significantly higher in AMI, UAP, and SAP patients compared to controls.
- IgE levels peaked by day 7 in AMI patients and persisted longer in UAP patients before gradually decreasing.
- Elevated blood eosinophil and basophil counts were observed in UAP and AMI patients, respectively, on admission.
Conclusions:
- IgE levels significantly increase during the acute phase of ACS, supporting the role of acute inflammatory response.
- Mast cell involvement in plaque rupture is supported by elevated IgE and inflammatory cell counts.
- Findings suggest IgE as a potential biomarker in acute coronary syndromes.